BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• Genetown

  Good Start Genetics, Inc. Presents New Data Further Validating Clinical Value Of Goodstart Select™ At PCRS Annual Meeting

  March 24, 2014

   · 

  1 min read
• Drug Development

  Provectus Pharmaceuticals Inc. Submits Application To FDA To Receive Breakthrough Therapy Designation For PV-10 For Treatment Of Melanoma

  March 24, 2014

   · 

  1 min read
• Drug Development

  Bristol-Myers Squibb Company To Present Data For Daclatasvir In Multiple Investigational All-Oral Combinations Across Hepatitis C Genotypes At The International Liver Congress™

  March 24, 2014

   · 

  1 min read
• BioMidwest

  St. Jude Medical Announces Global Launch Of Optisure Defibrillation Lead

  March 24, 2014

   · 

  1 min read
• Genetown

  Enanta Pharmaceuticals, Inc. Announces Data Presentations On Regimens Containing Protease Inhibitor ABT-450 To Be Presented At The European Association For The Study Of The Liver (EASL) Meeting

  March 24, 2014

   · 

  1 min read
• Biotech Beach

  Metactive Debuts Novel Embolization Technology With Presentation At The Society Of Interventional Radiology’s Annual Scientific Meeting

  March 24, 2014

   · 

  1 min read
• Drug Development

  Pfizer Inc. Announces Detailed Results Of OPT Compare Phase 3 Study Of Tofacitinib 5 Mg And 10 Mg Twice Daily Compared To High-Dose ENBREL® In Adults With Moderate-To-Severe Chronic Plaque Psoriasis

  March 24, 2014

   · 

  1 min read
• Antibe Therapeutics Inc. Announces Non-Brokered Private Placement Of $3,000,000

  March 24, 2014

   · 

  1 min read
• Genetown

  Advanced Cell Technology To Present At Regenenerative Medicine Investor Day March 26, 2014

  March 24, 2014

   · 

  1 min read
• Drug Development

  CytRx Corporation Initiates Pivotal Global Phase 3 Clinical Trial With Aldoxorubicin For Second-Line Treatment Of Soft Tissue Sarcoma

  March 24, 2014

   · 

  1 min read